Scholarly Works

Pexelizumab Does Not “Complement” Percutaneous...

Journal article

Pexelizumab Does Not “Complement” Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction

Authors

Eikelboom JW; O’Donnell M

Journal

JAMA: The Journal of the American Medical Association, Vol. 297, No. 1, pp. 91–92

Publisher

American Medical Association (AMA)

Publication Date

January 3, 2007

DOI

10.1001/jama.297.1.91

ISSN

0098-7484

Associated Experts

John Eikelboom

Professor, FHSMED

Martin O'Donnell

Associate Clinical Professor, FHSMED

Labels

Fields of Research (FoR)

32 Biomedical and clinical sciences 42 Health sciences

Medical Subject Headings (MeSH)

Angioplasty, Balloon, Coronary Anti-Inflammatory Agents Antibodies, Monoclonal Antibodies, Monoclonal, Humanized Humans Myocardial Infarction Single-Chain Antibodies

View published work (Non-McMaster Users)

View published work (McMaster Users)

Contact the Experts team

Get technical help

or

Provide website feedback